Show simple item record

dc.contributor.authorKivelä AM
dc.contributor.authorHuusko J
dc.contributor.authorGurzeler E
dc.contributor.authorLaine A
dc.contributor.authorDijkstra MH
dc.contributor.authorDragneva G
dc.contributor.authorAndersen CB
dc.contributor.authorMoestrup SK
dc.contributor.authorYlä-Herttuala S
dc.date.accessioned2017-11-29T08:46:38Z
dc.date.available2017-11-29T08:46:38Z
dc.date.issued2017
dc.identifier.urihttps://erepo.uef.fi/handle/123456789/5011
dc.description.abstractAdenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could significantly decrease adenoviral transduction efficiency in vivo. Here we demonstrate that mice on a high fat diet have lower transgene expression compared to mice on a regular chow. In addition, on a high fat diet, ApoE−/− mice have much higher plasma transgene levels compared to LDLR-deficient mice. We also found that specific lipoprotein receptors play an important role in adenoviral transduction. These findings suggest that high plasma lipid levels, especially apoE-containing lipoproteins, reduce efficacy of adenoviral transduction in mice, which implies that high cholesterol levels in humans could be protective against viral infections and also lead to insufficient transgene expression in clinical trials using adenoviral vectors.en
dc.language.isoENen
dc.relation.ispartofseriesScientific Reportsen
dc.relation.urihttp://dx.doi.org/10.1038/s41598-017-00376-5en
dc.rightsCC BY 4.0
dc.subjectGene therapyen
dc.subjectMolecular medicineen
dc.titleHigh Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapyen
dc.description.versionpublished versionen
dc.contributor.departmentA.I. Virtanen -instituuttien
uef.solecris.id48173648en
dc.type.publicationinfo:eu-repo/semantics/articleen
dc.relation.projectidinfo:eu-repo/grantAgreement/EC/FP7-IDEAS-ERC/250050/EU/Gene transfer techniques in the treatment of cardiovascular diseases and malignant glioma/FUTUREGENESen
dc.relation.doi10.1038/s41598-017-00376-5en
dc.description.reviewstatuspeerRevieweden
dc.relation.articlenumber386en
dc.relation.issn2045-2322en
dc.relation.numberinseries386en
dc.relation.volume7en
dc.rights.accesslevelopenAccessen
dc.type.okmA1en
dc.type.versioninfo:eu-repo/semantics/publishedVersionen
dc.rights.copyright© Authors
dc.type.displayTypearticleen
dc.type.displayTypeartikkelifi
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record